A detailed history of Marion Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Marion Wealth Management holds 3,149 shares of ABT stock, worth $321,575. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,149
Previous 3,087 2.01%
Holding current value
$321,575
Previous $339,000 5.31%
% of portfolio
0.11%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 08, 2024

BUY
$109.52 - $120.96 $6,790 - $7,499
62 Added 2.01%
3,149 $357,000
Q4 2023

Jan 10, 2024

SELL
$90.19 - $110.4 $21,555 - $26,385
-239 Reduced 7.19%
3,087 $339,000
Q3 2023

Oct 18, 2023

BUY
$95.53 - $114.62 $45,472 - $54,559
476 Added 16.7%
3,326 $322,000
Q2 2023

Jul 24, 2023

BUY
$100.78 - $112.29 $100 - $112
1 Added 0.04%
2,850 $310,000
Q1 2023

Apr 24, 2023

BUY
$96.86 - $114.01 $275,954 - $324,814
2,849 New
2,849 $288,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Marion Wealth Management Portfolio

Follow Marion Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marion Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Marion Wealth Management with notifications on news.